(Q36696590)

15 August 2017

Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange (English)

1 reference

15 August 2017

1 reference

Hesham Abboud

1

1 reference

15 August 2017

Alex Petrak

2

1 reference

15 August 2017

Maureen Mealy

3

1 reference

15 August 2017

Sarana Sasidharan

4

1 reference

15 August 2017

Laila Siddique

5

1 reference

15 August 2017

Michael Levy

6

1 reference

15 August 2017

28 April 2015

1 reference

15 August 2017

8

1 reference

Multiple Sclerosis Journal

inferred from page(s)

published in

1 reference

15 August 2017

22

1 reference

15 August 2017

2

1 reference

15 August 2017

185-192

1 reference

Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Treatment of Neuromyelitis Optica: Review and Recommendations.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Therapeutic plasma exchange in neuromyelitis optica: a case series

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Plasma exchange in severe attacks of neuromyelitis optica

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

The rescue effect of plasma exchange for neuromyelitis optica

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Revised diagnostic criteria for neuromyelitis optica

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

The clinical course of neuromyelitis optica (Devic's syndrome).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4795457

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

5 September 2018

1 reference

12 December 2020

Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica

1 reference

12 December 2020

A secondary progressive clinical course is uncommon in neuromyelitis optica

1 reference

12 December 2020

Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy

1 reference

12 December 2020

Identifiers

DOI

10.1177/1352458515581438

1 reference

15 August 2017

1 reference

15 August 2017

1 reference